KYOWA KIRIN CO., LTD.
- Country
- π―π΅Japan
- Ownership
- Public, Subsidiary
- Established
- 1949-07-01
- Employees
- 5.9K
- Market Cap
- -
- Website
- http://www.kyowa-kirin.co.jp
A Study of KRN23 in Subjects With X-linked Hypophosphatemic Rickets/Osteomalacia
- First Posted Date
- 2014-07-04
- Last Posted Date
- 2017-03-03
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 15
- Registration Number
- NCT02181764
The Effect of Rifampin on the Metabolism of Istradefylline in Healthy Volunteers.
- Conditions
- Parkinson's Disease
- Interventions
- First Posted Date
- 2014-06-25
- Last Posted Date
- 2024-04-25
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT02174250
- Locations
- πΊπΈ
Celerion, Inc., Tempe, Arizona, United States
Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Peritoneal Dialysis
- Conditions
- Secondary Hyperparathyroidism
- Interventions
- Drug: KHK7580
- First Posted Date
- 2014-05-21
- Last Posted Date
- 2015-03-05
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 13
- Registration Number
- NCT02143271
- Locations
- π―π΅
Kyowa Hakko Kirin, Tokyo, Japan
A Study of Single and Multiple Doses of KHK6640 in Subjects With Prodromal or Mild to Moderate Alzheimer's Disease
- First Posted Date
- 2014-04-30
- Last Posted Date
- 2024-06-17
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 57
- Registration Number
- NCT02127476
- Locations
- π³π±
Department of Neurology and Alzheimer Center, VU University Medical Center, Amsterdam, Netherlands
π³π±University Medical Centre Groningen (UMCG), Alzheimer Research Centre, Groningen, Netherlands
π§πͺUZ Gent, De Pintelaan 185, Gent, Belgium
Observational Study for Non-motor Symptoms and Treatment in Parkinson's Disease Patients
- Conditions
- Parkinson Disease
- First Posted Date
- 2014-02-28
- Last Posted Date
- 2023-08-07
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 1021
- Registration Number
- NCT02073981
- Locations
- π―π΅
Juntendo University Hospital, Bunkyo-ku, Tokyo, Japan
A Phase 3 Clinical Study of KHK 4827
- Conditions
- Psoriatic ArthritisPustular; Psoriasis, Palmaris Et PlantarisPsoriasis VulgarisPsoriatic Erythroderma
- Interventions
- Drug: KHK4827 140mg SCDrug: KHK4827 210mg SC
- First Posted Date
- 2014-02-03
- Last Posted Date
- 2023-08-25
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 155
- Registration Number
- NCT02052609
- Locations
- π―π΅
For additional information regarding investigative sites for this trial, contact Kyowa Kirin, Chiyoda-ku, Tokyo, Japan
A Randomized Double-blind, Placebo-controlled Japanese Phase III Trial of ARQ 197 in Hepatocellular Carcinoma (HCC)
- First Posted Date
- 2014-01-07
- Last Posted Date
- 2017-10-09
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 386
- Registration Number
- NCT02029157
- Locations
- π―π΅
Cancer Centers in Japan, Tokyo, Japan
Phase 2 Study of KHK4577
- First Posted Date
- 2013-12-06
- Last Posted Date
- 2018-09-11
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 93
- Registration Number
- NCT02004119
- Locations
- π―π΅
For additional information regarding investigative sites for this trial, contact Kyowa Hakko Kirin, Sapporo, Hokkaido, Japan
A 12-week Randomized Study to Evaluate Oral Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
- Conditions
- Idiopathic Parkinson's Disease
- Interventions
- First Posted Date
- 2013-10-23
- Last Posted Date
- 2024-04-25
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 613
- Registration Number
- NCT01968031
- Locations
- π·πΈ
Kyowa PD Site 2, Belgrade, Serbia
π·πΈKyowa PD Site, Novi Sad, Serbia
π·πΈKyowa PD Site 1, Belgrade, Serbia
Phase 1/2 Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis
- Conditions
- Hyperparathyroidism
- Interventions
- Drug: KHK7580
- First Posted Date
- 2013-09-05
- Last Posted Date
- 2017-03-03
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT01935856
- Locations
- π―π΅
For additional information regarding investigative sites for this trial, contact Kyowa Hakko Kirin, Tokyo, Japan